Hui-wen Liu

Company: Resilience

Job title: Sr. Scientist, Analytical Development, Gene Therapy Franchise

Seminars:

In-process rAAV genome titer assays on QIAcuity—a fully integrated and scalable digital PCR platform 4:00 pm

As gene therapy programs grow in number and scale, manufacturing processes must keep pace with demand by providing the speed, throughput, and automation necessary for advancement. Droplet digital PCR is the current gold standard for quantifying rAAV genomes but suffers from a long turn-around time and low throughput. The QIAcuity dPCR system provides a fully…Read more

day: Day One